No Data
Bank of America Securities Remains a Buy on Sana Biotechnology (SANA)
Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results
Express News | HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $12 Price Target
Sana Biotechnology Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 61.18% HC Wainwright & Co. → $12 Reiterates Buy → Buy 03/01/2024 101.48% JMP Securities $8 → $1
Express News | Sana Biotechnology Shares Are Trading Lower After the Company Reported Q1 Financial Results
Novo Nordisk, Flagship to Develop Next-generation Obesity Drugs